 Michael Cripps
Concepts (294)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholecystectomy, Laparoscopic | 7 | 2023 | 46 | 3.830 |
Why?
| | Wounds and Injuries | 13 | 2022 | 822 | 2.340 |
Why?
| | Cholecystitis, Acute | 5 | 2023 | 16 | 2.130 |
Why?
| | Venous Thromboembolism | 5 | 2023 | 235 | 1.950 |
Why?
| | Cholecystitis | 3 | 2023 | 17 | 1.620 |
Why?
| | Appendicitis | 4 | 2020 | 131 | 1.460 |
Why?
| | Anticoagulants | 5 | 2023 | 582 | 1.340 |
Why?
| | Emergency Treatment | 2 | 2020 | 113 | 1.330 |
Why?
| | Postoperative Complications | 6 | 2021 | 2321 | 1.190 |
Why?
| | Appendectomy | 3 | 2020 | 75 | 0.980 |
Why?
| | Hemorrhage | 5 | 2021 | 647 | 0.980 |
Why?
| | Trauma Centers | 9 | 2023 | 412 | 0.980 |
Why?
| | Retrospective Studies | 29 | 2023 | 13053 | 0.890 |
Why?
| | Simulation Training | 2 | 2022 | 65 | 0.880 |
Why?
| | Time-to-Treatment | 2 | 2020 | 161 | 0.830 |
Why?
| | Abdomen | 2 | 2018 | 122 | 0.810 |
Why?
| | Rib Fractures | 1 | 2021 | 25 | 0.800 |
Why?
| | Pain Management | 2 | 2021 | 303 | 0.770 |
Why?
| | Length of Stay | 7 | 2021 | 1056 | 0.760 |
Why?
| | Nerve Block | 1 | 2021 | 67 | 0.760 |
Why?
| | Critical Pathways | 1 | 2021 | 75 | 0.760 |
Why?
| | Enoxaparin | 3 | 2023 | 53 | 0.750 |
Why?
| | Emergency Medical Services | 2 | 2023 | 553 | 0.740 |
Why?
| | Blood Coagulation | 2 | 2018 | 234 | 0.720 |
Why?
| | Data Interpretation, Statistical | 1 | 2021 | 343 | 0.720 |
Why?
| | Burns | 3 | 2017 | 249 | 0.710 |
Why?
| | Elective Surgical Procedures | 1 | 2020 | 169 | 0.700 |
Why?
| | Specialties, Surgical | 1 | 2020 | 72 | 0.700 |
Why?
| | Kaolin | 1 | 2018 | 6 | 0.690 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2019 | 35 | 0.690 |
Why?
| | Factor Xa | 1 | 2018 | 35 | 0.690 |
Why?
| | Machine Learning | 1 | 2022 | 343 | 0.670 |
Why?
| | Vitamin K | 1 | 2018 | 45 | 0.670 |
Why?
| | Airway Extubation | 1 | 2018 | 45 | 0.660 |
Why?
| | Hemostatics | 1 | 2018 | 49 | 0.660 |
Why?
| | Laparoscopy | 2 | 2022 | 421 | 0.640 |
Why?
| | Thrombelastography | 2 | 2019 | 251 | 0.640 |
Why?
| | End Stage Liver Disease | 1 | 2019 | 80 | 0.640 |
Why?
| | Operative Time | 5 | 2023 | 116 | 0.630 |
Why?
| | Atrial Flutter | 1 | 2017 | 30 | 0.620 |
Why?
| | Severity of Illness Index | 4 | 2022 | 2876 | 0.620 |
Why?
| | Adult | 31 | 2021 | 32638 | 0.620 |
Why?
| | Tachycardia, Supraventricular | 1 | 2017 | 44 | 0.610 |
Why?
| | Appendix | 1 | 2017 | 28 | 0.610 |
Why?
| | Clinical Trials as Topic | 1 | 2021 | 1011 | 0.580 |
Why?
| | Injury Severity Score | 7 | 2020 | 544 | 0.570 |
Why?
| | Humans | 60 | 2023 | 121723 | 0.560 |
Why?
| | Middle Aged | 27 | 2021 | 28928 | 0.560 |
Why?
| | Internship and Residency | 3 | 2022 | 1045 | 0.550 |
Why?
| | Critical Illness | 2 | 2019 | 663 | 0.550 |
Why?
| | Patient Safety | 1 | 2018 | 308 | 0.540 |
Why?
| | Blood Transfusion | 2 | 2018 | 306 | 0.530 |
Why?
| | Biomedical Research | 1 | 2021 | 631 | 0.520 |
Why?
| | Shock, Hemorrhagic | 4 | 2021 | 241 | 0.520 |
Why?
| | Treatment Outcome | 16 | 2023 | 9648 | 0.520 |
Why?
| | Prospective Studies | 13 | 2022 | 6625 | 0.500 |
Why?
| | Hospitalization | 3 | 2022 | 1873 | 0.500 |
Why?
| | Male | 35 | 2021 | 60425 | 0.490 |
Why?
| | Female | 37 | 2021 | 63833 | 0.480 |
Why?
| | Resuscitation | 6 | 2022 | 278 | 0.480 |
Why?
| | Clinical Competence | 2 | 2022 | 956 | 0.450 |
Why?
| | Atrial Fibrillation | 1 | 2017 | 403 | 0.440 |
Why?
| | Texas | 4 | 2019 | 191 | 0.410 |
Why?
| | Wandering Spleen | 1 | 2010 | 2 | 0.390 |
Why?
| | Hand-Assisted Laparoscopy | 1 | 2010 | 3 | 0.390 |
Why?
| | Operating Rooms | 3 | 2022 | 90 | 0.380 |
Why?
| | Head Injuries, Penetrating | 1 | 2009 | 8 | 0.350 |
Why?
| | Outpatient Clinics, Hospital | 2 | 2020 | 84 | 0.350 |
Why?
| | Safety-net Providers | 3 | 2019 | 110 | 0.340 |
Why?
| | Risk Assessment | 10 | 2021 | 3245 | 0.340 |
Why?
| | Abdominal Abscess | 2 | 2020 | 25 | 0.340 |
Why?
| | Geriatric Assessment | 2 | 2020 | 187 | 0.340 |
Why?
| | Multiple Trauma | 1 | 2009 | 96 | 0.330 |
Why?
| | Aged | 14 | 2021 | 20688 | 0.320 |
Why?
| | Time Factors | 9 | 2020 | 6885 | 0.320 |
Why?
| | Blood Coagulation Tests | 2 | 2018 | 67 | 0.320 |
Why?
| | Mass Screening | 3 | 2020 | 1089 | 0.320 |
Why?
| | Wounds, Gunshot | 2 | 2017 | 170 | 0.310 |
Why?
| | Pneumonia, Ventilator-Associated | 2 | 2018 | 44 | 0.310 |
Why?
| | Hospitals | 2 | 2022 | 598 | 0.310 |
Why?
| | Triage | 1 | 2009 | 208 | 0.290 |
Why?
| | Choledocholithiasis | 2 | 2015 | 13 | 0.280 |
Why?
| | Reproducibility of Results | 5 | 2021 | 2996 | 0.270 |
Why?
| | Predictive Value of Tests | 4 | 2022 | 1963 | 0.270 |
Why?
| | Cause of Death | 3 | 2017 | 400 | 0.270 |
Why?
| | Young Adult | 8 | 2020 | 11215 | 0.250 |
Why?
| | Emergency Service, Hospital | 4 | 2023 | 1840 | 0.220 |
Why?
| | ROC Curve | 2 | 2022 | 496 | 0.220 |
Why?
| | Surveys and Questionnaires | 5 | 2023 | 4915 | 0.220 |
Why?
| | Time Perception | 1 | 2022 | 23 | 0.220 |
Why?
| | Health Plan Implementation | 2 | 2020 | 128 | 0.220 |
Why?
| | Patient Handoff | 1 | 2021 | 31 | 0.210 |
Why?
| | Balloon Occlusion | 1 | 2021 | 25 | 0.210 |
Why?
| | Adolescent | 5 | 2023 | 19118 | 0.210 |
Why?
| | Aged, 80 and over | 5 | 2020 | 6964 | 0.210 |
Why?
| | Intubation, Intratracheal | 1 | 2023 | 211 | 0.210 |
Why?
| | General Surgery | 2 | 2020 | 149 | 0.210 |
Why?
| | Paraspinal Muscles | 1 | 2021 | 8 | 0.200 |
Why?
| | Observational Studies as Topic | 1 | 2021 | 85 | 0.200 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2021 | 1253 | 0.200 |
Why?
| | Trauma Severity Indices | 1 | 2021 | 132 | 0.200 |
Why?
| | Anesthetics, Local | 1 | 2021 | 84 | 0.190 |
Why?
| | Soft Tissue Infections | 1 | 2020 | 31 | 0.190 |
Why?
| | Bias | 1 | 2021 | 203 | 0.190 |
Why?
| | United States Social Security Administration | 1 | 2019 | 1 | 0.190 |
Why?
| | Diphenoxylate | 1 | 2019 | 5 | 0.190 |
Why?
| | Laparotomy | 1 | 2020 | 113 | 0.190 |
Why?
| | Ileus | 1 | 2019 | 13 | 0.190 |
Why?
| | Loperamide | 1 | 2019 | 12 | 0.190 |
Why?
| | Mycoses | 1 | 2020 | 72 | 0.190 |
Why?
| | Metoclopramide | 1 | 2019 | 18 | 0.190 |
Why?
| | Erythromycin | 1 | 2019 | 26 | 0.180 |
Why?
| | Fasciitis, Necrotizing | 1 | 2019 | 11 | 0.180 |
Why?
| | Diet Therapy | 1 | 2019 | 38 | 0.180 |
Why?
| | Antifungal Agents | 1 | 2020 | 140 | 0.180 |
Why?
| | Surgicenters | 1 | 2019 | 8 | 0.180 |
Why?
| | Abdominal Wound Closure Techniques | 1 | 2018 | 8 | 0.180 |
Why?
| | Abdominal Injuries | 1 | 2020 | 120 | 0.170 |
Why?
| | Tertiary Care Centers | 1 | 2019 | 125 | 0.170 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2019 | 52 | 0.170 |
Why?
| | Viscoelastic Substances | 1 | 2018 | 9 | 0.170 |
Why?
| | Conversion to Open Surgery | 1 | 2018 | 13 | 0.170 |
Why?
| | Pipecolic Acids | 1 | 2018 | 24 | 0.170 |
Why?
| | Dabigatran | 1 | 2018 | 29 | 0.170 |
Why?
| | Hospitals, University | 1 | 2019 | 183 | 0.170 |
Why?
| | Surgical Wound Infection | 1 | 2021 | 253 | 0.170 |
Why?
| | Bandages | 1 | 2018 | 29 | 0.170 |
Why?
| | Risk Factors | 6 | 2023 | 9403 | 0.170 |
Why?
| | Diarrhea | 1 | 2019 | 180 | 0.170 |
Why?
| | Program Evaluation | 2 | 2020 | 876 | 0.170 |
Why?
| | Photoperiod | 1 | 2018 | 59 | 0.170 |
Why?
| | Brain Injuries, Traumatic | 1 | 2023 | 315 | 0.170 |
Why?
| | Antithrombins | 1 | 2018 | 57 | 0.170 |
Why?
| | Publishing | 1 | 2020 | 161 | 0.160 |
Why?
| | Efficiency, Organizational | 1 | 2019 | 131 | 0.160 |
Why?
| | Multidetector Computed Tomography | 1 | 2017 | 29 | 0.160 |
Why?
| | Myocardial Contusions | 1 | 2017 | 1 | 0.160 |
Why?
| | Enteral Nutrition | 1 | 2019 | 172 | 0.160 |
Why?
| | Hospital Mortality | 5 | 2020 | 876 | 0.160 |
Why?
| | Thorax | 1 | 2017 | 48 | 0.160 |
Why?
| | Emergencies | 1 | 2018 | 161 | 0.160 |
Why?
| | Logistic Models | 3 | 2019 | 2036 | 0.160 |
Why?
| | Surgical Procedures, Operative | 1 | 2020 | 230 | 0.160 |
Why?
| | Thoracic Vertebrae | 1 | 2017 | 70 | 0.160 |
Why?
| | Factor Xa Inhibitors | 1 | 2018 | 141 | 0.160 |
Why?
| | Endovascular Procedures | 1 | 2021 | 284 | 0.160 |
Why?
| | Smartphone | 1 | 2018 | 69 | 0.160 |
Why?
| | Accidental Falls | 1 | 2020 | 164 | 0.160 |
Why?
| | Information Storage and Retrieval | 1 | 2018 | 152 | 0.160 |
Why?
| | Police | 1 | 2017 | 36 | 0.150 |
Why?
| | Arginine | 1 | 2018 | 261 | 0.150 |
Why?
| | Patient Transfer | 1 | 2019 | 165 | 0.150 |
Why?
| | Tachycardia | 1 | 2017 | 59 | 0.150 |
Why?
| | Quality Improvement | 3 | 2020 | 996 | 0.150 |
Why?
| | Blood Viscosity | 1 | 2016 | 23 | 0.150 |
Why?
| | Spinal Injuries | 1 | 2017 | 52 | 0.150 |
Why?
| | Pelvis | 1 | 2017 | 92 | 0.150 |
Why?
| | Cohort Studies | 3 | 2020 | 5296 | 0.150 |
Why?
| | Heparin | 1 | 2018 | 243 | 0.150 |
Why?
| | Rivaroxaban | 1 | 2018 | 207 | 0.150 |
Why?
| | Physical Therapy Modalities | 1 | 2020 | 282 | 0.150 |
Why?
| | Occupational Injuries | 1 | 2017 | 57 | 0.150 |
Why?
| | Research Design | 1 | 2023 | 1003 | 0.150 |
Why?
| | Substance Abuse Detection | 1 | 2017 | 65 | 0.140 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 558 | 0.140 |
Why?
| | Critical Care | 1 | 2021 | 528 | 0.140 |
Why?
| | Blood Loss, Surgical | 1 | 2016 | 90 | 0.140 |
Why?
| | Cholecystectomy | 3 | 2023 | 45 | 0.140 |
Why?
| | Radiography, Interventional | 1 | 2016 | 102 | 0.140 |
Why?
| | Lumbar Vertebrae | 1 | 2017 | 219 | 0.140 |
Why?
| | Blood Safety | 1 | 2015 | 9 | 0.140 |
Why?
| | Decision Support Systems, Clinical | 1 | 2018 | 177 | 0.140 |
Why?
| | Platelet Transfusion | 1 | 2016 | 72 | 0.140 |
Why?
| | Medical Marijuana | 1 | 2017 | 105 | 0.130 |
Why?
| | Sulfonamides | 1 | 2018 | 458 | 0.130 |
Why?
| | Violence | 1 | 2017 | 221 | 0.130 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2018 | 424 | 0.130 |
Why?
| | Cryopreservation | 1 | 2015 | 103 | 0.130 |
Why?
| | Education, Medical, Graduate | 1 | 2018 | 424 | 0.120 |
Why?
| | Benchmarking | 1 | 2015 | 180 | 0.120 |
Why?
| | Exsanguination | 1 | 2013 | 21 | 0.120 |
Why?
| | Erythrocyte Transfusion | 1 | 2015 | 210 | 0.120 |
Why?
| | Burn Units | 3 | 2019 | 26 | 0.120 |
Why?
| | Blood Coagulation Disorders | 1 | 2016 | 260 | 0.120 |
Why?
| | Chronic Pain | 1 | 2017 | 211 | 0.120 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1574 | 0.110 |
Why?
| | Diagnostic Imaging | 1 | 2015 | 298 | 0.110 |
Why?
| | Glasgow Coma Scale | 1 | 2013 | 159 | 0.110 |
Why?
| | Patient Discharge | 1 | 2019 | 843 | 0.110 |
Why?
| | Practice Guidelines as Topic | 1 | 2021 | 1511 | 0.110 |
Why?
| | United States | 8 | 2022 | 13174 | 0.110 |
Why?
| | Suicide | 1 | 2018 | 480 | 0.110 |
Why?
| | Decision Support Techniques | 1 | 2016 | 394 | 0.110 |
Why?
| | Antifibrinolytic Agents | 1 | 2012 | 55 | 0.110 |
Why?
| | Blood Preservation | 1 | 2015 | 298 | 0.100 |
Why?
| | Child Abuse | 1 | 2016 | 456 | 0.100 |
Why?
| | Age Factors | 4 | 2020 | 3172 | 0.100 |
Why?
| | Surgical Mesh | 1 | 2010 | 39 | 0.090 |
Why?
| | Gastrointestinal Motility | 2 | 2019 | 27 | 0.090 |
Why?
| | Malaria | 1 | 2010 | 61 | 0.090 |
Why?
| | Splanchnic Circulation | 1 | 2009 | 13 | 0.090 |
Why?
| | Tungsten | 1 | 2009 | 27 | 0.090 |
Why?
| | Brain Injuries | 1 | 2014 | 506 | 0.090 |
Why?
| | Xanthine Oxidase | 1 | 2009 | 82 | 0.090 |
Why?
| | Survival Rate | 3 | 2020 | 1828 | 0.090 |
Why?
| | Capillary Permeability | 1 | 2009 | 140 | 0.080 |
Why?
| | Follow-Up Studies | 4 | 2020 | 4880 | 0.080 |
Why?
| | Substance-Related Disorders | 1 | 2017 | 958 | 0.080 |
Why?
| | Databases, Factual | 3 | 2019 | 1285 | 0.080 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 2 | 2021 | 180 | 0.070 |
Why?
| | HIV Infections | 1 | 2019 | 2506 | 0.070 |
Why?
| | Combined Modality Therapy | 2 | 2020 | 1200 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 2 | 2014 | 2519 | 0.060 |
Why?
| | Patient Acuity | 1 | 2023 | 38 | 0.060 |
Why?
| | Comorbidity | 2 | 2019 | 1630 | 0.060 |
Why?
| | Registries | 2 | 2022 | 1956 | 0.060 |
Why?
| | Hypoxia | 1 | 2009 | 981 | 0.060 |
Why?
| | Delphi Technique | 1 | 2023 | 154 | 0.060 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 4698 | 0.050 |
Why?
| | Incidence | 2 | 2018 | 2519 | 0.050 |
Why?
| | Consensus | 1 | 2023 | 537 | 0.050 |
Why?
| | Renal Replacement Therapy | 1 | 2020 | 64 | 0.050 |
Why?
| | Antidiarrheals | 1 | 2019 | 16 | 0.050 |
Why?
| | Data Collection | 1 | 2022 | 676 | 0.040 |
Why?
| | Necrosis | 1 | 2020 | 241 | 0.040 |
Why?
| | Fungi | 1 | 2020 | 123 | 0.040 |
Why?
| | Debridement | 1 | 2019 | 94 | 0.040 |
Why?
| | Educational Measurement | 1 | 2022 | 297 | 0.040 |
Why?
| | Aorta | 1 | 2021 | 374 | 0.040 |
Why?
| | Early Medical Intervention | 1 | 2019 | 52 | 0.040 |
Why?
| | Gastrointestinal Agents | 1 | 2019 | 61 | 0.040 |
Why?
| | Independent Living | 1 | 2020 | 86 | 0.040 |
Why?
| | Population Dynamics | 1 | 2019 | 144 | 0.040 |
Why?
| | Leadership | 1 | 2022 | 317 | 0.040 |
Why?
| | Prognosis | 2 | 2018 | 3601 | 0.040 |
Why?
| | Hospital Costs | 1 | 2019 | 117 | 0.040 |
Why?
| | Organizational Innovation | 1 | 2019 | 141 | 0.040 |
Why?
| | California | 1 | 2019 | 385 | 0.040 |
Why?
| | Likelihood Functions | 1 | 2017 | 144 | 0.040 |
Why?
| | Postural Balance | 1 | 2020 | 205 | 0.040 |
Why?
| | Homicide | 1 | 2017 | 49 | 0.040 |
Why?
| | Probability | 1 | 2017 | 326 | 0.040 |
Why?
| | Acute Disease | 1 | 2019 | 986 | 0.040 |
Why?
| | Counseling | 1 | 2019 | 363 | 0.040 |
Why?
| | Respiration, Artificial | 1 | 2020 | 568 | 0.040 |
Why?
| | Burns, Chemical | 1 | 2016 | 27 | 0.040 |
Why?
| | Elasticity | 1 | 2016 | 188 | 0.040 |
Why?
| | Accidents, Traffic | 1 | 2017 | 177 | 0.040 |
Why?
| | Ambulatory Care | 1 | 2020 | 493 | 0.040 |
Why?
| | Biliary Tract | 1 | 2015 | 16 | 0.040 |
Why?
| | Dilatation, Pathologic | 1 | 2015 | 62 | 0.030 |
Why?
| | Communication | 1 | 2021 | 755 | 0.030 |
Why?
| | Self-Injurious Behavior | 1 | 2017 | 128 | 0.030 |
Why?
| | Propensity Score | 1 | 2017 | 250 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2017 | 221 | 0.030 |
Why?
| | Blood Banks | 1 | 2015 | 50 | 0.030 |
Why?
| | Liver Function Tests | 1 | 2015 | 117 | 0.030 |
Why?
| | Age Distribution | 1 | 2016 | 386 | 0.030 |
Why?
| | Reference Values | 1 | 2017 | 804 | 0.030 |
Why?
| | Hospitals, Urban | 1 | 2015 | 139 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1472 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2019 | 552 | 0.030 |
Why?
| | Pain Measurement | 1 | 2017 | 484 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2015 | 435 | 0.030 |
Why?
| | Risk | 1 | 2017 | 921 | 0.030 |
Why?
| | Liver Diseases | 1 | 2017 | 324 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1190 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1356 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2014 | 249 | 0.030 |
Why?
| | Prevalence | 1 | 2019 | 2440 | 0.030 |
Why?
| | International Normalized Ratio | 1 | 2012 | 51 | 0.030 |
Why?
| | Partial Thromboplastin Time | 1 | 2012 | 57 | 0.030 |
Why?
| | Platelet Count | 1 | 2012 | 93 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2015 | 1383 | 0.030 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2012 | 83 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 2014 | 257 | 0.030 |
Why?
| | Ultrasonography | 1 | 2015 | 736 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2015 | 1719 | 0.020 |
Why?
| | Sex Factors | 1 | 2017 | 1898 | 0.020 |
Why?
| | Alcoholism | 1 | 2017 | 808 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2019 | 1491 | 0.020 |
Why?
| | Venules | 1 | 2009 | 13 | 0.020 |
Why?
| | Mesocricetus | 1 | 2009 | 34 | 0.020 |
Why?
| | Reperfusion | 1 | 2009 | 45 | 0.020 |
Why?
| | Cricetinae | 1 | 2009 | 274 | 0.020 |
Why?
| | Disease Progression | 1 | 2014 | 2581 | 0.020 |
Why?
| | Pregnancy | 1 | 2017 | 5660 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2547 | 0.010 |
Why?
| | Infant | 1 | 2016 | 8439 | 0.010 |
Why?
| | Child, Preschool | 1 | 2016 | 9771 | 0.010 |
Why?
| | Diet | 1 | 2009 | 1163 | 0.010 |
Why?
| | Rats | 1 | 2009 | 5516 | 0.010 |
Why?
| | Child | 1 | 2016 | 19271 | 0.010 |
Why?
| | Animals | 1 | 2009 | 34126 | 0.000 |
Why?
|
|
Cripps's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|